Hema is a Clinical Research Fellow with the Gram Positive Molecular Pathogenesis group led by Professor Shiranee Sriskandan at the Centre for Infection Prevention and Management. Her area of research is in Staphylococcus aureus superantigens.
et al., 2019, Toxic shock syndrome toxin-1 evaluation and antibiotic impact in a transgenic model of staphylococcal soft tissue infection, Msphere, Vol:4, ISSN:2379-5042
et al., 2017, Ochromobactrum intermedium: an emerging opportunistic pathogen—case of recurrent bacteraemia associated with infective endocarditis in a haemodialysis patient, New Microbes and New Infections, Vol:15, ISSN:2052-2975, Pages:14-15
et al., 2016, The selective outpatient treatment of adults with imported falciparum malaria: a prospective cohort study, Qjm, Vol:109, ISSN:1460-2725, Pages:181-186
et al., 2013, THE EXPRESSION OF TSST-1 BY EMRSA-16, W B SAUNDERS CO LTD, Pages:346-346, ISSN:0163-4453
et al., 2013, Expression of toxic shock syndrome toxin-1 by epidemic meticillin-resistant Staphylococcus aureus 16, Spring Meeting for Clinician Scientists in Training, ELSEVIER SCIENCE INC, Pages:98-98, ISSN:0140-6736